To include your compound in the COVID-19 Resource Center, submit it here.

NPS proposes follow-on

NPS Pharmaceuticals Inc. (NASDAQ:NPSP) proposed late Monday to sell 9

Read the full 108 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE